ENDOTHELIAL AND IMMUNOLOGICAL CHANGES IN COMPRESS ION-ISCHEMIC RADICULOMYELOPATHY AND THEIR ENERGY CORRECTION
DOI:
https://doi.org/10.11603/2415-8798.2018.2.8924Keywords:
radiculomyelopathy, immune-inflammatory process, energy metabolism.Abstract
The pathological process of compression-ischemic radiculomyelopathy (CIRMP ) is accompanied by high energy costs. Therefore, topical is the use of drugs that improve energy metabolism in hypoxic conditions.
The aim of the study – to investigate the features of the immuno-inflammatory process in CIRMP under the influence of meldonium.
Materials and Methods. The parameters of 45 patients with CIRMP were investigated. All patients received conventional therapy. Patients of the group 1 (26 patients) received meldonium additionally, and in the group 2 (the main one – 19 patients) included "capicor". The levels of endothelin-1, cGMP , NO , interleukin-1β and -4, tumor necrosis factor-α were studied, aggregation properties of platelets were studied.
Results and Discussion. Against the background of the treatment of patients with the use of meldonium and meldonium+γ-butyrobetan dihydrate, positive changes in the biochemical parameters: endothelin-1, cGMP , NO , interleukins 1β and 4, tumor necrosis factor α, aggregation properties of platelets, improvement of the function of the endothelium and blood circulation in the microvessels of the rootlets, which, in turn, led to the restoration of the functional state of roots and spinal cord.
Conclusions. The use of meldonium and meldonium+γ-butyrobetaine in the therapy of patients with CIRMP was accompanied by a regression of clinical manifestations, which is associated with an improvement in blood circulation in the vessels of the spinal roots and back muscles. A more pronounced effect was influenced by meldonium in combination with γ-butyrobetaine.
References
Prodan, A.I., Perepechay, O.A., Podlipentsev, V.V., Chernyshev, A.G. & Shimon, M.V. (2008). Patofiziologiya vertebrogennoy radikulopatii. Kontseptualnaya model [Pathophysiology of vertebrogenic radiculopathy. Conceptual model]. Litopys travmatolohii ta ortopedii – Chronicle of traumatology and orthopedics, 1-2, 209-216 [in Russian].
Yavorska, N.P. (2011). Bil: vid molekliarnykh mekhanizmiv do klinichnykh aspektiv [Pain: from muscular mechanisms to clinical aspects]. Mizhnarodnyi nevrolohichnyi zhurnal – International Neurological Journal, 3 (41), 1–16 [in Ukrainian].
Popelyanskiy, Ya.Yu. (2003). Ortopedicheskaya nevrologiya (vertebronevrologiya) [Orthopedic neurology (vertebroneurology)]. Moskva: MEDpress-inform, 670 p. [in Rus-sian].
Selmi, C., Barin, J.G., & Rose, N.R. (2016). Current trends in autoimmunity and the nervous system. J. Autoimmun, 75, 20-29. doi: 10.1016/j.jaut.2016.08.005
Belenichev, I.F., Pavlov, S.V. & Bukhtiyarova, N.V. (2009). Mekhanizmy formirovaniya ishemicheskoy neyrodestruktsii: sootnoshenie oksida azota i tiol-disul'fidnoy sistemy, kak faktor, opredelyayushchiy sud'bu neyrona [Mechanisms of for-mation of ischemic neurodestruction: the ratio of nitric oxide and thiol-disulphide system, as a factor determining the fate of a neuron]. Mezhdunarodnyy nevrologicheskiy zhurnal – International Neurological Journal, 8 (30), 100-106 [in Russian].
Kuznetsova, S.M. (Ed.) (2015). Novye vozmozhnosti antiishemicheskoy terapii i vosstanovleniya funktsii endoteliya [New opportunities for anti-ischemic therapy and re-covery of endothelial function]: materialy XVII Mezhdunarodnoy konferentsii «Ot pato-fiziologii k ratsional'noy terapii v nevrologi» (2015 aprel 5 Truskavets). Truskavets, 37 p. [in Russian].
Pokrovskiy, V.I. & Vinogradov, N.A. (2005). Oksid azota i ego fiziologicheskie i patofiziologicheskie svoystva [Nitric oxide and its physiological and pathophysiological properties]. Terapevticheskiy arkhiv, 1, 82-87 [in Russian].
Cabrera, C. & Bohr, D. (2001). The role of nitric oxide in the central control of blood pressure. Biochem. Biophys. Res. Commun., 206, 77-81. doi: 10.1006/bbrc.1995.1011
Verma S., Buchanan, M.R. & Anderson, T.J. (2003). Endothelial function testing as a biomarker of vascular disease. Circulation, 108 (17), 2054-2059. doi: 10.1161/01.CIR.0000089191.72957.ED
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
